Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Olerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study.
Tabar AI, Fernández-Távora L, Alonso R, Castillo R, Cisteró-Bahima A, de la Torre-Morin F, Fernández J, García-Figueroa BE, Fernández S, García-González JJ, García-Robaina JC, Moreno F, Lobatón P, Sánchez-Machín I, de la Torre-Martínez F. Tabar AI, et al. Among authors: fernandez tavora l. J Investig Allergol Clin Immunol. 2004;14(3):193-7. J Investig Allergol Clin Immunol. 2004. PMID: 15552712
Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units.
Moreno C, Fernández-Távora L, Acero S, Alonso MD, Barasona MJ, Blanco R, Cisteró A, Conde J, Fernández J, Fernández S, Fernández-Rivas M, García BE, García-Rodríguez R, Camacho E, González-Quevedo T, Gonzalo A, Guardia P, Sánchez-Cano M, Tabar AI, de la Torre F. Moreno C, et al. Among authors: fernandez tavora l. J Investig Allergol Clin Immunol. 2003;13(4):221-7. J Investig Allergol Clin Immunol. 2003. PMID: 14989109
Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.
Moreno C, Cuesta-Herranz J, Fernández-Távora L, Alvarez-Cuesta E; Immunotherapy Committee, Sociedad Española de Alergología e Inmunología Clínica. Moreno C, et al. Among authors: fernandez tavora l. Clin Exp Allergy. 2004 Apr;34(4):527-31. doi: 10.1111/j.1365-2222.2004.1819.x. Clin Exp Allergy. 2004. PMID: 15080803
Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P, Justicia JL, Sánchez C, Cimarra M, Fernández-Távora L, Orovitg A, Moreno C, Guerra F, Alvà V. Serrano P, et al. Among authors: fernandez tavora l. Ann Allergy Asthma Immunol. 2009 Mar;102(3):247-52. doi: 10.1016/S1081-1206(10)60088-9. Ann Allergy Asthma Immunol. 2009. PMID: 19354072
Clustered schedules in allergen-specific immunotherapy.
Parmiani S, Fernández Távora L, Moreno C, Guardia P, Rico P. Parmiani S, et al. Among authors: fernandez tavora l. Allergol Immunopathol (Madr). 2002 Sep-Oct;30(5):283-91. doi: 10.1016/s0301-0546(02)79138-6. Allergol Immunopathol (Madr). 2002. PMID: 12396963 Review.